ILLUMINA VENTURES

SQZ Biotechnologies: On a quest to revolutionize cell therapy

December 2020 - “SQZ has developed an approach to cell therapy manufacturing that could have a major impact on the industry,” said Alexis Ji, Partner at Illumina Ventures. “We are excited about the prospects of creating cell therapies that are less expensive and can be delivered to patients much more rapidly.”